<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Posts on Rheumatology Digest</title><link>https://rheumatologydigest.org/posts/</link><description>Recent content in Posts on Rheumatology Digest</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Wed, 13 May 2026 10:00:00 +0530</lastBuildDate><atom:link href="https://rheumatologydigest.org/posts/index.xml" rel="self" type="application/rss+xml"/><item><title>Clinical conditions associated with a high ANA titer in non-autoimmune individuals</title><link>https://rheumatologydigest.org/posts/high-ana-titer-non-autoimmune/</link><pubDate>Wed, 13 May 2026 10:00:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/high-ana-titer-non-autoimmune/</guid><description>In a 28,781-patient EMR phenome-wide study, a high ANA titer (≥1:640) without autoimmune disease was strongly enriched for non-AI liver disease (NAFLD/NASH, alcohol-related) and metabolic comorbidity — broadening the differential for an unexplained high-titer ANA beyond the usual autoimmune workup.</description></item><item><title>Cellular therapies for rheumatic disease</title><link>https://rheumatologydigest.org/posts/cellular-therapies-for-rheumatic-disease/</link><pubDate>Mon, 11 May 2026 17:30:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/cellular-therapies-for-rheumatic-disease/</guid><description>CD19 CAR-T cellular therapy delivers drug-free remission in 80–85% of refractory SLE patients in early-phase trials, with similar signals in IIM and SSc — the first credible attempt at true immunological reset in autoimmune rheumatic disease.</description></item><item><title>Welcome to Rheumatology Digest</title><link>https://rheumatologydigest.org/posts/welcome-to-rheumatology-digest/</link><pubDate>Mon, 11 May 2026 09:00:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/welcome-to-rheumatology-digest/</guid><description>A new permanent home for Rheumatology Digest — daily clinical write-ups, cases, quizzes, and learning modules.</description></item></channel></rss>